相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Alternative splicing of hTERT: a further mechanism for the control of active hTERT in acute myeloid leukemia
Celeste Calvello et al.
LEUKEMIA & LYMPHOMA (2018)
Mutant IDH1 Cooperates with ATRX Loss to Drive the Alternative Lengthening of Telomere Phenotype in Glioma
Joydeep Mukherjee et al.
CANCER RESEARCH (2018)
Telomere Length Maintenance in Cancer: At the Crossroad between Telomerase and Alternative Lengthening of Telomeres (ALT)
Marco De Vitis et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Alternative Splicing of hTERT Pre-mRNA: A Potential Strategy for the Regulation of Telomerase Activity
Xuewen Liu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Insights From Molecular Profiling of Adult Glioma
Phedias Diamandis et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Changes in telomerase activity due to alternative splicing of human telomerase reverse transcriptase in colorectal cancer
Hei Cheul Jeung et al.
ONCOLOGY LETTERS (2017)
CX-5461 is a DNA G-quadruplex stabilizer with selective lethality in BRCA1/2 deficient tumours
Hong Xu et al.
NATURE COMMUNICATIONS (2017)
Adult infiltrating gliomas with WHO 2016 integrated diagnosis: additional prognostic roles of ATRX and TERT
Melike Pekmezci et al.
ACTA NEUROPATHOLOGICA (2017)
A splicing variant of TERT identified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancer
Alice W. Lee et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Human telomerase reverse transcriptase regulation by DNA methylation, transcription factor binding and alternative splicing (Review)
Brittany A. Avin et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
CX-5461 induces autophagy and inhibits tumor growth via mammalian target of rapamycin-related signaling pathways in osteosarcoma
Leiming Li et al.
ONCOTARGETS AND THERAPY (2016)
Role of Telomeres and Telomerase in Aging and Cancer
Jerry W. Shay
CANCER DISCOVERY (2016)
Inhibition of RNA polymerase I transcription initiation by CX-5461 activates non-canonical ATM/ATR signaling
Jaclyn Quin et al.
ONCOTARGET (2016)
Alternative lengthening of telomeres renders cancer cells hypersensitive to ATR inhibitors
Rachel Litman Flynn et al.
SCIENCE (2015)
Telomerase-Dependent and Independent Telomere Maintenance and its Clinical Implications in Medullary Thyroid Carcinoma
Na Wang et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Alternative splicing regulation of telomerase: a new paradigm?
Mandy S. Wong et al.
TRENDS IN GENETICS (2014)
Physiological and pathological significance of human telomerase reverse transcriptase splice variants
F. Mathias Bollmann
BIOCHIMIE (2013)
The Major Reverse Transcriptase-Incompetent Splice Variant of the Human Telomerase Protein Inhibits Telomerase Activity but Protects from Apoptosis
Imke Listerman et al.
CANCER RESEARCH (2013)
Telomere length and expression of human telomerase reverse transcriptase splice variants in chronic lymphocytic leukemia
Marzia Palma et al.
EXPERIMENTAL HEMATOLOGY (2013)
The architecture of Tetrahymena telomerase holoenzyme
Jiansen Jiang et al.
NATURE (2013)
Prognostic significance of telomerase-associated parameters in glioblastoma: effect of patient age
Daniela Loetsch et al.
NEURO-ONCOLOGY (2013)
Regulation of Telomerase Alternative Splicing: A Target for Chemotherapy
Mandy S. Wong et al.
CELL REPORTS (2013)
Human telomerase expression regulation
Marta Gladych et al.
BIOCHEMISTRY AND CELL BIOLOGY (2011)
Ionizing Radiation Up-regulates Telomerase Activity in Cancer Cell Lines by Post-translational Mechanism via Ras/Phosphatidylinositol 3-Kinase/Akt Pathway
Ron Ram et al.
CLINICAL CANCER RESEARCH (2009)
Differential hTERT mRNA processing between young and older glioma patients
A. Shervington et al.
FEBS LETTERS (2008)
Telomerase subunits expression variation between biopsy samples and cell lines derived from malignant glioma
Amal Shervington et al.
BRAIN RESEARCH (2007)
Association of mutant TP53 with alternative lengthening of telomeres and favorable prognosis in glioma
Yu-Jen Chen et al.
CANCER RESEARCH (2006)
Differential expression of full-length telomerase reverse transcriptase mRNA and telomerase activity between normal and malignant renal tissues
YD Fan et al.
CLINICAL CANCER RESEARCH (2005)
Oligomer-mediated modulation of hTERT alternative splicing induces telomerase inhibition and cell growth decline in human prostate cancer cells
C Brambilla et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2004)
Telomerase downregulation induced by the G-quadruplex ligand 12459 in A549 cells is mediated by hTERT RNA alternative splicing
D Gomez et al.
NUCLEIC ACIDS RESEARCH (2004)
DNA damage foci at dysfunctional telomeres
H Takai et al.
CURRENT BIOLOGY (2003)
Expression profile of a γ-deletion variant of the human telomerase reverse transcriptase gene
H Hisatomi et al.
NEOPLASIA (2003)
Alternative lengthening of telomeres and survival in patients with glioblastoma multiforme
V Hakin-Smith et al.
LANCET (2003)
Full-length telomerase reverse transcriptase messenger RNA is an independent prognostic factor in neuroblastoma
M Krams et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Clinical implications of quantitative real-time RT-PCR analysis of hTERT gene expression in human gliomas
A Tchirkov et al.
BRITISH JOURNAL OF CANCER (2003)
Human telomeric DNA: G-quadruplex, i-motif and watson-crick double helix
AT Phan et al.
NUCLEIC ACIDS RESEARCH (2002)
The human telomerase gene:: complete genomic sequence and analysis of tandem repeat polymorphisms in intronic regions
SH Leem et al.
ONCOGENE (2002)
Histone H2AX is phosphorylated in an ATR-dependent manner in response to replicational stress.
IM Ward et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Regulation of telomerase activity by alternate splicing of human telomerase reverse transcriptase mRNA in a subset of neuroblastomas
M Krams et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
In vitro generated antibodies specific for telomeric guanine-quadruplex DNA react with Stylonychia lemnae macronuclei
C Schaffitzel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Telomerase activation, cellular immortalization and cancer
WC Hahn et al.
ANNALS OF MEDICINE (2001)
The hTERTα splice variant is a dominant negative inhibitor of telomerase activity
LM Colgin et al.
NEOPLASIA (2000)
分享论文
